Abstract
Staphylococcus aureus has been a major cause of hospital-acquired infections. Methicillin-resistant Staphylococcus aureus (MRSA) has emerged since 1980s as an epidemiologic problem in hospitals. This old pathogen brings a new challenge to all physicians and bacteriologists. Hence, effective measures of MRSA control are in critical need. S. aureus or MRSA is one of the leading causes of infection among burn centers, resulting in a number of poor outcomes and even death. The present study performed a molecular epidemiologic analysis of S. aureus isolated from four burn centers in the southeast of China. A total of 85 isolates were collected, and molecular characters were determined for further investigation. In this study, the prevalent clone of MRSA among four burn centers was found to be SCCmec III (spa-type t030, agr I), which is resistant to 4 kinds of antimicrobials including erythromycin, clindamycin, kanamycin and mupirocin. Discrepancy between mecA detection and conventional tests used for MRSA identification was observed unintentionally. Our data demonstrated that the overall prevalence rate of MRSA was 55.3%, and drugs such as sulfamethoxazole/trimethoprim, linezolid and fusidic acid are efficient antibiotic options for...Continue Reading
References
Apr 1, 1991·Antimicrobial Agents and Chemotherapy·H de LencastreA Tomasz
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·S UnalG Eliopoulos
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·Y KatayamaK Hiramatsu
Jan 18, 2002·Infection and Immunity·Sophie JarraudFrançois Vandenesch
Feb 9, 2002·Burns : Journal of the International Society for Burn Injuries·Pia AppelgrenUlrika Ransjö
May 24, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pak-Leung HoWing-Hong Seto
Mar 21, 2008·Journal of Burn Care & Research : Official Publication of the American Burn Association·Wade DansbyJames Luby
Sep 29, 2009·Diagnostic Microbiology and Infectious Disease·Håvard ValvatneRuud H Deurenberg
Mar 31, 2010·Emerging Infectious Diseases·Li-Zhong HanYi-Bo Zhang
Citations
Sep 17, 2013·PloS One·Xu ChenYu-Xing Ni
Dec 29, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Najmeh ParhizgariMahmood Naraki
Mar 19, 2013·Burns : Journal of the International Society for Burn Injuries·Effat Abbasi-MontazeriDavood Darban-Sarokhalil
Mar 12, 2015·Surgical Infections·Fei-Fei GuYu-Xing Ni
Apr 30, 2015·PloS One·Fei-Fei GuLi-Zhong Han
Jul 28, 2016·BMC Infectious Diseases·Xiaoying XieSongyin Huang
Feb 27, 2016·Annals of Laboratory Medicine·Xu ChenFuxiang Chen
Nov 17, 2016·Journal of Biomaterials Science. Polymer Edition·Xinxin ChenCe Wang
Mar 23, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yang LiuWei Zhang
Jan 10, 2018·Frontiers in Microbiology·Bei JiangYizhi Peng
Sep 21, 2016·Chinese Medical Journal·Fei-Fei GuLi-Zhong Han
Jan 27, 2018·BMC Infectious Diseases·Kaisen ChenWei Zhang
Mar 14, 2018·BMC Infectious Diseases·Xiaoying XieSongyin Huang
Aug 1, 2019·Anais Da Academia Brasileira De Ciências·Saravana Kumar Jaganathan, Mohan P Mani
Sep 5, 2015·PloS One·Ji ZhangLi-Zhong Han
Apr 6, 2017·Frontiers in Microbiology·Zhen SongLi-Zhong Han
Apr 1, 2016·Ci Ji Yi Xue Za Zhi = Tzu-chi Medical Journal·Rashedul HasanRashed Noor
Oct 9, 2018·Frontiers in Physiology·Chunbo YangAndriana Margariti
Mar 1, 2018·Frontiers in Microbiology·Parisa AsadollahiDavood Darban-Sarokhalil
Nov 7, 2019·Frontiers in Cellular and Infection Microbiology·Yao XiaoJian-Jun Niu
May 3, 2021·Antimicrobial Resistance and Infection Control·Bahareh HajikhaniMasoud Dadashi
Jun 5, 2021·Toxicon : Official Journal of the International Society on Toxinology·Parvaneh BevalianKamran Pooshang Bagheri